Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8M Buy
67,657
+1,314
+2% +$152K 0.04% 321
2026
Q1
$7.93M Buy
66,343
+2,144
+3% +$281K 0.05% 303
2025
Q4
$8.74M Buy
64,199
+2,377
+4% +$342K 0.06% 278
2025
Q3
$9.12M Buy
61,822
+2,339
+4% +$324K 0.06% 258
2025
Q2
$7.69M Buy
59,483
+3,683
+7% +$446K 0.06% 269
2025
Q1
$6.67M Buy
55,800
+3,124
+6% +$387K 0.06% 282
2024
Q4
$6.11M Buy
52,676
+3,197
+6% +$404K 0.06% 295
2024
Q3
$6.68M Buy
49,479
+3,279
+7% +$439K 0.07% 267
2024
Q2
$6.27M Buy
46,200
+3,783
+9% +$515K 0.07% 256
2024
Q1
$5.48M Buy
42,417
+194
+0.5% +$23.4K 0.07% 267
2023
Q4
$4.83M Buy
42,223
+132
+0.3% +$13.2K 0.07% 277
2023
Q3
$3.83M Buy
42,091
+13,767
+49% +$1.42M 0.06% 295
2023
Q2
$3.19M Buy
28,324
+7,095
+33% +$750K 0.07% 273
2023
Q1
$2.22M Buy
21,229
+134
+0.6% +$14K 0.05% 330
2022
Q4
$2.33M Buy
21,095
+151
+0.7% +$15.8K 0.06% 318
2022
Q3
$1.83M Buy
+20,944
New +$1.9M 0.05% 348

Other funds holding XYL

Czech National Bank's XYL Position: Q2 2026 in Review

Czech National Bank increased its Xylem (XYL) stake by 2% in Q2 2026, buying an estimated $152K and bringing the position to 67,657 shares worth $8M. The position accounts for 0.04% of the portfolio, ranked #321.

Czech National Bank first reported a position in XYL in Q3 2022 and has held it in 16 quarters since. The position peaked at $9.12M in Q3 2025. 340 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Czech National Bank held 67,657 shares of Xylem worth $8M as of Q2 2026.
  • Czech National Bank bought 1,314 Xylem shares in Q2 2026, an estimated $152K.
  • Xylem made up 0.04% of Czech National Bank's portfolio in Q2 2026, its #321 holding.
  • Czech National Bank first reported a position in Xylem in Q3 2022 and has held it in 16 quarters since.
  • Czech National Bank's Xylem position peaked at $9.12M in Q3 2025.
  • 340 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.